Most Clicked StoriesMore >


U.S. needs to reform discovery, development, delivery of drugs

BIO SmartBrief | Aug 26, 2014

U.S. regulators need to guarantee rewards for innovation, promote wider data sharing while protecting privacy and improve the existing drug-development model, write Nobel Prize winner Phillip Sharp, Tufts Center for the Study of Drug Development Director Kenneth Kaitin and former FDA Commissioner Dr. Andrew von Eschenbach. Because Massachusetts is a leader in life sciences innovation, it is the right place to examine greater ways to incentivize innovative drugmakers for bringing greater value to patients, they write. The state can only maintain and expand its leadership in the life-sciences sector if the U.S. changes its process of discovering, developing and delivering better drugs to patients, they write. Boston Herald (08/24)


Roche boosts respiratory drug pipeline with $8.3B InterMune buy

BIO SmartBrief | Aug 25, 2014

Illumina partners with firms to develop universal oncology test

BIO SmartBrief | Aug 22, 2014

MorphoSys signs prostate cancer drug deal with Emergent BioSolutions

BIO SmartBrief | Aug 21, 2014

Study: Spike in drug withdrawals coincides with FDA safety initiatives

BIO SmartBrief | Aug 22, 2014

BIO to hold livestock biotech summit in S.D.

BIO SmartBrief | Aug 20, 2014

Price caps hurt innovation, patients' access to drugs

BIO SmartBrief | Aug 20, 2014

Biotech food labeling makes "no scientific sense"

BIO SmartBrief | Aug 21, 2014

Deep sequencing technique might find mutations missed by whole genome sequencing

BIO SmartBrief | Aug 22, 2014

GSK's asthma treatment Arnuity Ellipta gains FDA approval

BIO SmartBrief | Aug 21, 2014


Find BIO SmartBrief Issues by Date:



BIO News More >


Summer 2014 BIO Therapeutic Newsletters

BIO SmartBrief | Aug 27, 2014

Present your industrial biotech research in San Diego

BIO SmartBrief | Aug 26, 2014

Registration is open for the BIO Investor Forum!

BIO SmartBrief | Aug 25, 2014

Housing & registration open for the BIO Pacific Rim Summit

BIO SmartBrief | Aug 22, 2014

New BIO Survey Tool: FDA/Sponsor Interactions During Drug Development

BIO SmartBrief | Aug 21, 2014




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more